Using selective adoptive CD8+ T cells transfer into Rag1−/− mice in vivo, endogenous S-2HG reduction alleviates the ischemic brain injury and post-stroke cognitive dysfunction with fewer brain-infiltrating CD8+ T lymphocytes. The gene discussed is CD8A; the disease is stroke disorder.